Abiopharma

🔍 Amouyal Philippe (Director)

Company: LEXICON PHARMACEUTICALS, INC. (LXRX)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 35,714 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 35,714.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 43,478 shares of Stock Option (Right to Buy) at $1.61 per share (Derivative)
  Date: 2026-05-01 | Code: A | Expires: 2036-05-01 | equity_swap_involved: 0 | shares_owned_after: 43,478.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
• F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
• F3: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.